Neptune Wellness Solutions Inc. NEPTF
0.00
0.00
NaN
as of 23 Sep
- Market cap
- $1.6M
- P/E
- 0.0×
Follow NEPTF
Growth Flags
show if company had growth for consecutive years
| Dec '23 | Sep '23 | Jun '23 | Mar '23 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.06 | 0.02 | 0.05 | 0.12 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(0.78) | 1.05 | (0.45) | (0.81) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.12 | 0.52 | 0.56 | 0.52 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(2.83) | (1.21) | (0.95) | (0.96) | |
EV/FCF |
(2.69) | (1.16) | (0.91) | (0.89) | |
Quick Ratio |
0.07 | 0.19 | 0.15 | 0.23 | |
Current Ratio |
0.23 | 0.47 | 0.48 | 0.57 | |
Net Debt/EBITDA |
(1.42) | (5.23) | (2.29) | (0.51) | |
Debt/Assets |
112.85% | 89.37% | 82.58% | 74.21% | |
Debt/Equity |
(0.50) | (0.70) | (0.71) | (0.83) | |
Asset Turnover |
0.90 | 0.92 | 0.73 | 0.77 | |
Operating CF/Net income |
0.17 | (0.85) | 0.64 | 0.30 | |
Capex/Depreciation |
0.00 | (0.37) | (0.01) | (0.46) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.01% | 0.28% | 0.21% | 0.27% | |
Selling, General and Administrative Expense of Revenue |
246.49% | 43.90% | 112.65% | 92.49% | |
Intangible Assets out of Total Assets |
0.16 | 0.13 | 0.13 | 0.13 | |
Share Based Compensation of Revenue |
5.70% | 5.35% | 5.80% | 5.53% | |
Graham Net Nets |
(24.88) | (56.44) | (17.91) | (5.48) | |
Graham Number |
180.58 | 386.74 | 727.88 | 757.43 | |
Earnings Yield |
(21,622.13%) | (9,136.72%) | (4,568.06%) | (1,264.81%) | |
Free Cash Flow Yield |
(691.72%) | (2,485.86%) | (1,204.29%) | (480.73%) | |
Revenue per Share |
1.77 | 13.51 | 26.24 | 41.14 | |
Operating CF per Share |
(0.71) | 1.17 | (13.08) | (26.74) | |
Capex per Share |
0.00 | (0.12) | (0.01) | (1.12) | |
Free Cash Flow per Share |
(0.71) | 1.06 | (13.09) | (27.85) | |
Cash per Share |
0.29 | 7.37 | 3.45 | 6.81 | |
Shareholders Equity per Share |
(12.19) | (59.15) | (87.67) | (93.33) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(12.19) | (59.15) | (87.67) | (93.33) | |
Free Cash Flow |
(3.03) | 0.68 | (5.30) | (8.23) | |
Working Capital |
(56.82) | (26.31) | (25.03) | (17.48) | |
Capital Expenditures |
0.00 | (0.08) | 0.00 | (0.33) | |
Net Current Asset Value |
(58.65) | (44.91) | (42.64) | (34.94) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.01 | 0.00 | 0.03 | |
Net Profit Margin |
(233.55%) | (10.19%) | (78.23%) | (213.59%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
4.41 | 4.77 | 6.08 | 7.55 | |
Average Payables |
26.68 | 26.40 | 25.39 | 24.88 | |
Average Inventory |
13.28 | 13.93 | 13.91 | 15.03 | |
Average Assets |
43.50 | 47.55 | 64.15 | 67.94 | |
Average Common Equity |
(18.15) | (11.33) | 9.14 | 16.64 |
Columns are period end dates